Carlota Calvo

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group

Albert Oriol, Susana Vives, Jesús María Hernández‐Rivas et al. · Haematologica · 2010 · 292 citations · Full text

Medicine, Oncology, Chemotherapy +14

Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy

Lourdes Martín‐Martín, Júlia Almeida, Helena Pomares et al. · Oncotarget · 2016 · 89 citations · Full text

Medicine, Hematology, Oncology +15

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

Josep‐María Ribera, Juan-José Ortega, Albert Oriol et al. · Journal of Clinical Oncology · 2006 · 55 citations

Medicine, Oncology, Pediatrics +17

Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.

Juan-José Ortega, Josep‐María Ribera, Albert Oriol et al. · PubMed · 2001 · 33 citations

Medicine, Oncology, Pediatrics +15

PD-1 is expressed in cytotoxic granules of NK cells and rapidly mobilized to the cell membrane following recognition of tumor cells

Cecilia Pesini, Sandra Hidalgo, Maykel Arias et al. · OncoImmunology · 2022 · 17 citations · Full text

Life Sciences, Immunology, Oncology +15